• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜透析中的肾素-血管紧张素-醛固酮系统:对肾脏有益的物质对腹膜也有益吗?

The renin-angiotensin-aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum?

机构信息

Division of Nephrology, Department of Medicine, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.

出版信息

Kidney Int. 2010 Jul;78(1):23-8. doi: 10.1038/ki.2010.90. Epub 2010 Mar 24.

DOI:10.1038/ki.2010.90
PMID:20336052
Abstract

Morphological changes of the peritoneal membrane that occur over time among patients on peritoneal dialysis include fibrosis and neoangiogenesis. While the pathophysiologic mechanisms underlying these changes are not fully understood, the activation of the renin-angiotensin-aldosterone system (RAAS) may have an important role. Components of the RAAS are constitutively expressed within peritoneal mesothelial cells, and are upregulated in the presence of acute inflammation and chronic exposure to peritoneal dialysate. The high glucose concentration, low pH, and the presence of glucose degradation products in peritoneal dialysis solutions have all been implicated in modulation of peritoneal RAAS. Furthermore, activation of the RAAS, as well as the downstream production of transforming growth factor-beta, contributes to epithelial-to-mesenchymal transformation of mesothelial cells, resulting in progressive fibrosis of the peritoneal membrane. This process also leads to increased vascular endothelial growth factor production, which promotes peritoneal neoangiogenesis. Functionally, these changes translate into reduced ultrafiltration capacity of the peritoneal membrane, which is an important cause of technique failure among patients on long-term peritoneal dialysis. This brief review will describe our current state of knowledge about the role of peritoneal RAAS in peritoneal membrane damage and potential strategies to protect the membrane.

摘要

腹膜透析患者腹膜的形态学变化包括纤维化和新生血管形成。虽然这些变化的病理生理机制尚未完全阐明,但肾素-血管紧张素-醛固酮系统(RAAS)的激活可能具有重要作用。RAAS 的成分在腹膜间皮细胞中持续表达,并在急性炎症和慢性暴露于腹膜透析液时上调。高葡萄糖浓度、低 pH 值以及腹膜透析液中葡萄糖降解产物的存在都与腹膜 RAAS 的调节有关。此外,RAAS 的激活以及下游转化生长因子-β的产生导致间皮细胞的上皮-间充质转化,导致腹膜的进行性纤维化。这个过程还导致血管内皮生长因子的产生增加,从而促进腹膜新生血管形成。从功能上讲,这些变化导致腹膜超滤能力下降,这是长期腹膜透析患者技术失败的一个重要原因。这篇简要综述将描述我们目前对腹膜 RAAS 在腹膜损伤中的作用以及保护腹膜的潜在策略的认识。

相似文献

1
The renin-angiotensin-aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum?腹膜透析中的肾素-血管紧张素-醛固酮系统:对肾脏有益的物质对腹膜也有益吗?
Kidney Int. 2010 Jul;78(1):23-8. doi: 10.1038/ki.2010.90. Epub 2010 Mar 24.
2
An update on RAAS blockade and peritoneal membrane preservation: the ace of art.肾素-血管紧张素-醛固酮系统(RAAS)阻断与腹膜完整性保护的最新进展:技术要点
J Med Assoc Thai. 2011 Sep;94 Suppl 4:S175-83.
3
Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.间皮细胞的间充质转化作为腹膜透析中高溶质转运率的一种机制:血管内皮生长因子的作用
Am J Kidney Dis. 2005 Nov;46(5):938-48. doi: 10.1053/j.ajkd.2005.08.011.
4
Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients.上皮-间质转化作为腹膜透析患者腹膜纤维化和血管生成的触发因素
Curr Opin Investig Drugs. 2005 Mar;6(3):262-8.
5
Inflammation, neoangiogenesis and fibrosis in peritoneal dialysis.腹膜透析中的炎症、新生血管形成和纤维化。
Clin Chim Acta. 2013 Jun 5;421:46-50. doi: 10.1016/j.cca.2013.02.027. Epub 2013 Mar 4.
6
Mediators of inflammation and fibrosis.炎症和纤维化的介质。
Perit Dial Int. 2007 Jun;27 Suppl 2:S65-71.
7
Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients.肾素-血管紧张素-醛固酮系统阻断药物对腹膜透析患者腹膜的影响。
Ther Apher Dial. 2013 Aug;17(4):425-30. doi: 10.1111/1744-9987.12091.
8
[Selected indices of peritoneal fibrosis in patients undergoing peritoneal dialysis].[接受腹膜透析患者腹膜纤维化的选定指标]
Postepy Hig Med Dosw (Online). 2009 Apr 30;63:200-4.
9
PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.过氧化物酶体增殖物激活受体-γ 激动剂罗格列酮可保护腹膜免受透析液损伤。
Lab Invest. 2010 Oct;90(10):1517-32. doi: 10.1038/labinvest.2010.111. Epub 2010 Jun 7.
10
Update on mechanisms of ultrafiltration failure.超滤失败机制的最新进展。
Perit Dial Int. 2009 Feb;29 Suppl 2:S123-7.

引用本文的文献

1
Dyslipidemia in Peritoneal Dialysis: Implications for Peritoneal Membrane Function and Patient Outcomes.腹膜透析中的血脂异常:对腹膜功能和患者预后的影响。
Biomedicines. 2024 Oct 17;12(10):2377. doi: 10.3390/biomedicines12102377.
2
Peritoneal and renal DKK3 clearance in peritoneal dialysis.腹膜和肾脏 DKK3 清除率在腹膜透析中的作用。
BMC Nephrol. 2024 Aug 23;25(1):268. doi: 10.1186/s12882-024-03715-7.
3
LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates epithelial-mesenchymal transition of peritoneal mesothelial cells and M2 macrophage polarization.
LCZ696,一种血管紧张素受体-脑啡肽酶抑制剂,可改善腹膜间皮细胞的上皮-间充质转化和 M2 巨噬细胞极化。
Ren Fail. 2024 Dec;46(2):2392849. doi: 10.1080/0886022X.2024.2392849. Epub 2024 Aug 21.
4
High Salt Promotes Inflammatory and Fibrotic Response in Peritoneal Cells.高盐促进腹腔细胞的炎症和纤维化反应。
Int J Mol Sci. 2023 Sep 6;24(18):13765. doi: 10.3390/ijms241813765.
5
Novel Aspects of the Immune Response Involved in the Peritoneal Damage in Chronic Kidney Disease Patients under Dialysis.慢性肾脏病透析患者腹膜损伤中免疫反应的新方面。
Int J Mol Sci. 2023 Mar 17;24(6):5763. doi: 10.3390/ijms24065763.
6
Possible benefits of exogenous melatonin for individuals on dialysis: a narrative review on potential mechanisms and clinical implications.外源性褪黑素对透析患者可能的益处:对潜在机制和临床意义的叙述性综述。
Naunyn Schmiedebergs Arch Pharmacol. 2021 Aug;394(8):1599-1611. doi: 10.1007/s00210-021-02099-x. Epub 2021 Jun 7.
7
IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis.白细胞介素-17A 作为腹膜透析患者的潜在治疗靶点。
Biomolecules. 2020 Sep 24;10(10):1361. doi: 10.3390/biom10101361.
8
Increased miR-7641 Levels in Peritoneal Hyalinizing Vasculopathy in Long-Term Peritoneal Dialysis Patients.长期腹膜透析患者腹膜玻璃样变血管病中 miR-7641 水平升高。
Int J Mol Sci. 2020 Aug 13;21(16):5824. doi: 10.3390/ijms21165824.
9
Valsartan ameliorates high glucose-induced peritoneal fibrosis by blocking mTORC1 signaling.缬沙坦通过阻断 mTORC1 信号通路改善高糖诱导的腹膜纤维化。
Exp Biol Med (Maywood). 2020 Jun;245(11):983-993. doi: 10.1177/1535370220919364. Epub 2020 May 14.
10
Clinical outcome of incident peritoneal dialysis patients with diabetic kidney disease.糖尿病肾病新发腹膜透析患者的临床结局
Clin Exp Nephrol. 2019 Mar;23(3):409-414. doi: 10.1007/s10157-018-1646-3. Epub 2018 Sep 25.